Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value ($000): $2,338,493 (100.0% shares, 0.0% debt)

Holdings (36)

ABIOMED INC 16.8%
Value ($000) $391,865 Shares 1,346,660 Est. Cost $32.04 Unrealized
CLOVIS ONCOLOGY INC 8.9%
Value ($000) $208,859 Shares 3,955,660 Est. Cost $54.18 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 8.8%
Value ($000) $206,362 Shares 2,545,482 Est. Cost $79.79 Unrealized +7.6%
UTHR UNITED THERAPEUTICS CORP DEL 7.8%
Value ($000) $182,319 Shares 1,622,631 Est. Cost $88.73 Unrealized +43.2%
INSM INSMED INC 6.9%
Value ($000) $161,234 Shares 7,159,590 Est. Cost $16.67 Unrealized +57.8%
SAGE THERAPEUTICS INC 5.6%
Value ($000) $131,809 Shares 818,331 Est. Cost $46.14 Unrealized
ALEXION PHARMACEUTICALS INC 5.4%
Value ($000) $126,601 Shares 1,135,845 Est. Cost $120.92 Unrealized
EPIZYME INC 5.2%
Value ($000) $122,388 Shares 6,895,075 Est. Cost $15.12 Unrealized
FOLD AMICUS THERAPEUTICS INC 4.0%
Value ($000) $92,463 Shares 6,147,829 Est. Cost $6.44 Unrealized +136.3%
IMMUNOMEDICS INC 3.0%
Value ($000) $70,070 Shares 4,796,008 Est. Cost $11.54 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.0%
Value ($000) $70,023 Shares 4,155,670 Est. Cost $8.70 Unrealized +92.3%
AMAG PHARMACEUTICALS INC 2.9%
Value ($000) $67,317 Shares 3,340,806 Est. Cost $29.37 Unrealized
ALGN ALIGN TECHNOLOGY INC 2.3%
Value ($000) $54,924 Shares 218,707 Est. Cost $98.66 Unrealized +160.3%
WRIGHT MED GROUP N V 2.3%
Value ($000) $54,606 Shares 2,752,294 Est. Cost $23.42 Unrealized
STAA STAAR SURGICAL CO 2.2%
Value ($000) $52,028 Shares 3,515,385 Est. Cost $8.00 Unrealized +95.2%
KARYOPHARM THERAPEUTICS INC 2.1%
Value ($000) $49,385 Shares 3,679,978 Est. Cost $19.34 Unrealized
AIMMUNE THERAPEUTICS INC 1.8%
Value ($000) $43,178 Shares 1,356,514 Est. Cost $23.73 Unrealized
PRTA PROTHENA CORP PLC 1.7%
Value ($000) $40,430 Shares 1,101,338 Est. Cost $32.98 Unrealized +10.3%
ACAD ACADIA PHARMACEUTICALS INC 1.6%
Value ($000) $37,093 Shares 1,650,780 Est. Cost $29.82 Unrealized -7.2%
CELGENE CORP 1.4%
Value ($000) $33,823 Shares 379,140 Est. Cost $96.18 Unrealized
MOMENTA PHARMACEUTICALS INC 1.4%
Value ($000) $33,222 Shares 1,830,435 Est. Cost $14.12 Unrealized
SHIRE PLC 1.2%
Value ($000) $28,563 Shares 191,200 Est. Cost $197.13 Unrealized
ALDER BIOPHARMACEUTICALS INC 1.0%
Value ($000) $23,493 Shares 1,849,832 Est. Cost $11.48 Unrealized
RIGEL PHARMACEUTICALS INC 0.6%
Value ($000) $14,040 Shares 3,966,087 Est. Cost $3.40 Unrealized
GILD GILEAD SCIENCES INC 0.6%
Value ($000) $13,261 Shares 175,900 Est. Cost $62.02 Unrealized -5.0%
EXAS EXACT SCIENCES CORP 0.5%
Value ($000) $12,612 Shares 312,719 Est. Cost $13.61 Unrealized +258.3%
DICERNA PHARMACEUTICALS INC 0.2%
Value ($000) $4,789 Shares 500,913 Est. Cost $5.39 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value ($000) $3,162 Shares 1,162,473 Est. Cost $4.37 Unrealized
ALIMERA SCIENCES INC 0.1%
Value ($000) $3,104 Shares 3,013,793 Est. Cost $4.88 Unrealized
ZOGENIX INC 0.1%
Value ($000) $1,181 Shares 29,500 Est. Cost $13.36 Unrealized
IDERA PHARMACEUTICALS INC 0.0%
Value ($000) $1,134 Shares 616,355 Est. Cost $3.70 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value ($000) $891 Shares 123,686 Est. Cost $6.71 Unrealized +27.7%
HISTOGENICS CORP 0.0%
Value ($000) $833 Shares 302,922 Est. Cost $11.00 Unrealized
TREVENA INC 0.0%
Value ($000) $560 Shares 341,300 Est. Cost $2.30 Unrealized
SOPHIRIS BIO INC 0.0%
Value ($000) $496 Shares 247,000 Est. Cost $2.60 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value ($000) $375 Shares 50,689 Est. Cost $15.80 Unrealized